GlassScriptPhysician profile
Kenneth B Trimmer
NPI 1124060975
$11,670.46
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,059 · 2020: $1,373 · 2021: $1,729 · 2022: $2,958 · 2023: $1,396 · 2024: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,552.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,357.57 | 2019-2023 | Gallant, Diamondback Coronary, Assurity |
| E.R. Squibb & Sons, L.L.C. | $997.44 | 2019-2023 | Camzyos, Eliquis |
| Medtronic, INC. | $926.94 | 2021-2023 | Linq II, Onyx Frontier, Micra |
| Penumbra, INC. | $879.25 | 2019-2020 | |
| Abiomed | $815.26 | 2019-2022 | |
| Medtronic Vascular, INC. | $729.17 | 2019-2020 | |
| Amgen INC. | $728.36 | 2019-2022 | |
| Cardiovascular Systems INC. | $603.98 | 2019-2023 | Diamondback Peripheral |
| Edwards Lifesciences Corporation | $567.44 | 2019-2023 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $506.93 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $474.46 | 2019-2023 | |
| Pfizer INC. | $461.90 | 2019-2023 | |
| Philips North America LLC | $312.70 | 2019-2022 | |
| Shockwave Medical, INC | $173.61 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.21 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $143.50 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $127.37 | 2019-2021 | |
| Esperion Therapeutics, INC. | $122.95 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $111.70 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $99.70 | 2019 | |
| Terumo Medical Corporation | $94.87 | 2022 | |
| Chiesi USA, INC. | $49.42 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $48.54 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $47.95 | 2019 | |
| Cardinal Health 200 LLC | $41.91 | 2019-2020 | |
| Biosense Webster, INC. | $27.59 | 2023 | Carto 3 |
| Actelion Pharmaceuticals US, INC. | $19.61 | 2019 | |
| Cook Medical LLC | $18.04 | 2022 | |
| Amarin Pharma, INC. | $16.69 | 2019 | |
| Cardiva Medical, INC. | $15.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Trimmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.